GlassScriptPhysician profile
Barry N Brass
NPI 1528128873
$528.92
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $263 · 2020: $35.62 · 2022: $17.02 · 2023: $129 · 2024: $84.70.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $213.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $283.43 | 2019-2024 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $34.49 | 2020-2023 | |
| Boston Scientific Corporation | $29.71 | 2019-2022 | |
| Optumhealth Care Solutions, LLC | $28.60 | 2023-2024 | Vivify Health Care Team Portal 001, Eitan Medical, Vivify Health Care Team Portal |
| Therapeuticsmd, INC. | $24.82 | 2019 | |
| Pfizer INC. | $23.27 | 2019 | |
| Abbvie INC. | $18.99 | 2019 | |
| Daiichi Sankyo INC. | $16.30 | 2019 | |
| Lsi Solutions INC | $15.78 | 2023 | Fornisee |
| Minerva Surgical, INC | $14.84 | 2019 | |
| Amgen INC. | $13.90 | 2019 | |
| Conmed Corporation | $13.08 | 2024 | Airseal |
| Avion Pharmaceuticals | $11.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Brass listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.